Direxion S&P Biotech Bull 3X ETF (LABU)

[value1008]

Me, too, unfortunately for all investors in biotechs and LABU. Those XBI lows of April-May 2014 ($39s - $41 area) are just begging to be tested and the HFT algos will most likely want to take the XBI down to see where support is this time around.

Just do the math on where leveraged LABU goes if XBI falls another 15% to 20%.
Not a pretty picture.....